Corporate News     10-Apr-17
Marksans Pharma gets final approval for Dutasteride Soft Gelatin Capsules
From USFDA
Marksans Pharma announced that on 07 April 2017, the USFDA has granted final approval of the Abbreviated New Drug Application for Dutasteride Soft Gelatin Capsules 0.5 mg, which is therapeutically equivalent to the reference listed drug (RLD), Avodart Capsules, 0.5 mg of GlaxoSmithKline.

Durasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Marksans will launch the product immediately.

Previous News
  Marksans Pharma fixes record date for dividend
 ( Market Beat - Reports 30-May-23   17:34 )
  Marksans Pharma receives USFDA approval for Guaifenesin ER Tablets
 ( Corporate News - 22-Aug-23   17:51 )
  Marksans Pharma receives USFDA approval for Esomeprazole Magnesium Delayed-Release Capsules
 ( Corporate News - 03-Oct-23   15:15 )
  Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
 ( Results - Announcements 13-Feb-23   14:08 )
  Board of Marksans Pharma appoints director
 ( Corporate News - 30-May-23   17:36 )
  Marksans Pharma gains on receiving USFDA approval for Guaifenesin tablets
 ( Hot Pursuit - 22-Aug-23   14:54 )
  Marksans Pharma arm receives EIR from USFDA
 ( Corporate News - 03-Nov-23   11:04 )
  Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:41 )
  Marksans Pharma receives UK MHRA approval for Bells Healthcare All in One Oral Solution
 ( Corporate News - 22-Feb-22   14:05 )
  Marksans Pharma commences buyback of shares
 ( Corporate News - 15-Jul-22   17:50 )
  Marksans Pharma announces UK MHRA nod for Bells Healthcare All in One Oral Solution
 ( Hot Pursuit - 22-Feb-22   15:15 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top